To further explore potential clinical applications of the experimental data, we assessed the relationship of YAP and GLUT1 expression levels in hepatocellular carcinoma tissue with clinicopathologic features of HCC patients. This evidence concerns the gene YAP1 and hepatocellular carcinoma.